masterThesis
Prevalencia de resistencia plaquetaria a clopidogrel en pacientes sometidos a intervencion coronaria percutanea
Fecha
2011Registro en:
TEME 0030 2011
Autor
De la Ossa Aguirre, Martin Rafael
Cabrales Arevalo, Jaime Ramon
Echeverry, Dario
Pineda, Mauricio
Medina, Libardo
Institución
Resumen
Antiplatelet agents are the mainstay of treatment for patients with syndromes
Acute Coronary have shown reduced risk of death, myocardial
infarction, and need for urgent revascularization. Some patients have events
major cardiac despite receiving these drugs. The impact of resistance
drugs has been material from multiple studies. In our study the prevalence of clopidogrel resistance by the method of platelet aggregometry
Light transfer samples taken between 7 and 10 days post angioplasty, is about
above the international average in our population, which warrants the implementation of new studies by the prognostic implications they may have in terms of adverse cardiovascular events.